Anand Surana – Director - Micro Lab of Micro Labs
View Detailed Executive Profile →Professional Overview
- Anand Surana serves as a director at Micro Labs Limited, a prominent pharmaceutical company based in Bangalore, which specializes in the production of generic drugs, including treatments for cardiac diseases and diabetes.
- Under Anand Surana's leadership, Micro Labs has gained recognition for its popular paracetamol brand, Dolo, which has become a household name in India, reflecting the company's commitment to quality and accessibility in healthcare.
- Anand Surana has been instrumental in steering Micro Labs to rank 18th in sales among organized pharmaceutical companies in India, showcasing the company's significant market presence and operational success.
- In addition to his role at Micro Labs, Anand Surana holds a directorial position at Micro Infrastructure India Private Limited, indicating a diversified approach to business management and investment.
- Since April 2010, Anand Surana has been a whole-time director at Micro Labs, contributing to strategic decision-making and operational oversight within the organization.
- Anand Surana's leadership has been pivotal in expanding Micro Labs' product portfolio, ensuring the company remains competitive in the rapidly evolving pharmaceutical landscape.
- The Surana family, including Anand and his brother Dilip, has played a crucial role in the growth and development of Micro Labs, emphasizing a family-oriented approach to business leadership.
- Anand Surana's educational background and professional experience have equipped them with the necessary skills to navigate the complexities of the pharmaceutical industry effectively.
- Through strategic partnerships and collaborations, Anand Surana has helped enhance Micro Labs' research and development capabilities, fostering innovation in drug formulation and delivery.
- Anand Surana's commitment to corporate social responsibility is reflected in Micro Labs' initiatives aimed at improving healthcare access and affordability for underserved populations.
- As a director, Anand Surana actively participates in shaping the company's vision and long-term goals, ensuring alignment with industry trends and consumer needs.
- Anand Surana's influence extends beyond the company, contributing to discussions on pharmaceutical regulations and industry standards within India.
- Through effective leadership, Anand Surana has cultivated a strong organizational culture at Micro Labs, focusing on employee development and retention, which is critical for sustaining growth.
- Anand Surana's strategic foresight has positioned Micro Labs to adapt to market changes, including the increasing demand for generic medications in both domestic and international markets.
- Overall, Anand Surana's contributions to Micro Labs and the pharmaceutical industry exemplify a commitment to innovation, quality, and community health improvement.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| RA CHEM PHARMA LIMITED | Additional Director | 30-Mar-2020 – 01-Apr-2020 |
| MICRO NUTRACEUTICALS PRIVATE LIMITED | Director | 29-May-2009 – 12-Dec-2014 |
| MICRO EROS PHARMACEUTICALS PRIVATE LIMIT ED | Director | 29-May-2009 – 12-Dec-2014 |
| GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Director | 28-Jun-2010 – 23-Nov-2013 |
| INDU INFRACON INDIA PRIVATE LIMITED | Director | 25-Aug-2011 – 23-Nov-2013 |
| MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Director | 17-Apr-2007 – 23-Nov-2013 |
| MICRO DERMACEUTICALS PRIVATE LIMITED | Director | 15-May-2009 – 12-Dec-2014 |
| VIM SOFT PRIVATE LIMITED | Director | 11-Nov-2005 – 12-Dec-2014 |
| MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Additional Director | 10-Oct-2019 – 24-Dec-2020 |
| MICRO VET PRIVATE LIMITED | Director | 10-Dec-2013 – 12-Dec-2014 |
| MICRO OPTHALMIC PRIVATE LIMITED | Director | 08-Jun-2009 – 12-Dec-2014 |
| MICRO NOVA PHARMACEUTICAL PRIVATE LIMITE D | Director | 08-Jun-2009 – 12-Dec-2014 |
| MICRO CARSYSON PRIVATE LIMITED | Director | 07-May-2009 – 12-Dec-2014 |
| DNR CORPORATION PRIVATE LIMITED | Director | 07-Dec-2007 – 23-Nov-2013 |
| GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Additional Director | 06-Nov-2018 – 31-Aug-2019 |
| VASISHTA PHARMACEUTICALS PRIVATE LIMITED | Additional Director | 05-Apr-2021 – 16-Jun-2021 |
| VNURTURE HEALTHCARE SOFTWARE SOLUTIONS PRIVATE LIMITED | Additional Director | 04-Feb-2021 – 30-Sep-2021 |
| RA CHEM PHARMA LIMITED | Managing Director | 01-Apr-2020 – 27-Oct-2020 |
| Micro Lab | Director | Present |
| GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Director | 31-Aug-2019 – Present |
| VNURTURE HEALTHCARE SOFTWARE SOLUTIONS PRIVATE LIMITED | Director | 30-Sep-2021 – Present |
| DNR BUILDCON LLP | Designated Partner | 25-Nov-2021 – Present |
| MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Director | 24-Dec-2020 – Present |
| BAHL AND COMPANY PRIVATE LIMITED | Director | 18-Sep-2015 – Present |
| CHITRAVELI INVESTMENTS LLP | Designated Partner | 16-Nov-2015 – Present |
| STERN CHEMPHARM LLP | Designated Partner | 09-Jan-2018 – Present |
| DNR INFRACON LLP | Designated Partner | 03-Feb-2020 – Present |
| MICRO LABS LIMITED | Whole-time director | 01-Apr-2010 – Present |
Current Appointments
| CIN/LLP | Company | Designation | Date |
|---|---|---|---|
| AAF-1704 | CHITRAVELI INVESTMENTS LLP | Designated Partner | 16-Nov-2015 |
| AAL-6618 | STERN CHEMPHARM LLP | Designated Partner | 09-Jan-2018 |
| AAN-4453 | DNR INFRACON LLP | Designated Partner | 03-Feb-2020 |
| AAQ-1809 | DNR BUILDCON LLP | Designated Partner | 25-Nov-2021 |
| U24232KA1973PLC002401 | MICRO LABS LIMITED | Whole-time director | 01-Apr-2010 |
| U45201KA2007PTC042509 | MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Director | 24-Dec-2020 |
| U65100KA2010PTC054250 | GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Director | 31-Aug-2019 |
| U67190KA1946PTC160479 | BAHL AND COMPANY PRIVATE LIMITED | Director | 18-Sep-2015 |
| U72900KA2007PTC158284 | VNURTURE HEALTHCARE SOFTWARE SOLUTIONS PRIVATE LIMITED | Director | 30-Sep-2021 |
Previous Appointments
| CIN/LLP | Company | Designation | Period |
|---|---|---|---|
| U24110TG1996PLC022816 | RA CHEM PHARMA LIMITED | Additional Director | 30-Mar-2020 – 01-Apr-2020 |
| U24110TG1996PLC022816 | RA CHEM PHARMA LIMITED | Managing Director | 01-Apr-2020 – 27-Oct-2020 |
| U24232KA2009PTC049781 | MICRO CARSYSON PRIVATE LIMITED | Director | 07-May-2009 – 12-Dec-2014 |
| U24232KA2009PTC049861 | MICRO DERMACEUTICALS PRIVATE LIMITED | Director | 15-May-2009 – 12-Dec-2014 |
| U24232KA2009PTC049993 | MICRO NUTRACEUTICALS PRIVATE LIMITED | Director | 29-May-2009 – 12-Dec-2014 |
| U24232KA2009PTC049994 | MICRO EROS PHARMACEUTICALS PRIVATE LIMIT ED | Director | 29-May-2009 – 12-Dec-2014 |
| U24232KA2009PTC050065 | MICRO OPTHALMIC PRIVATE LIMITED | Director | 08-Jun-2009 – 12-Dec-2014 |
| U24232KA2009PTC050066 | MICRO NOVA PHARMACEUTICAL PRIVATE LIMITE D | Director | 08-Jun-2009 – 12-Dec-2014 |
| U24301KA2013PTC072425 | MICRO VET PRIVATE LIMITED | Director | 10-Dec-2013 – 12-Dec-2014 |
| U45200KA2011PTC060147 | INDU INFRACON INDIA PRIVATE LIMITED | Director | 25-Aug-2011 – 23-Nov-2013 |
| U45201KA2007PTC042509 | MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Additional Director | 10-Oct-2019 – 24-Dec-2020 |
| U45201KA2007PTC042509 | MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Director | 17-Apr-2007 – 23-Nov-2013 |
| U45201KA2007PTC044602 | DNR CORPORATION PRIVATE LIMITED | Director | 07-Dec-2007 – 23-Nov-2013 |
| U51397KA2008PTC047872 | VASISHTA PHARMACEUTICALS PRIVATE LIMITED | Additional Director | 05-Apr-2021 – 16-Jun-2021 |
| U65100KA2010PTC054250 | GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Additional Director | 06-Nov-2018 – 31-Aug-2019 |
| U65100KA2010PTC054250 | GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Director | 28-Jun-2010 – 23-Nov-2013 |
| U72300KA1997PTC022610 | VIM SOFT PRIVATE LIMITED | Director | 11-Nov-2005 – 12-Dec-2014 |
| U72900KA2007PTC158284 | VNURTURE HEALTHCARE SOFTWARE SOLUTIONS PRIVATE LIMITED | Additional Director | 04-Feb-2021 – 30-Sep-2021 |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Micro Labs corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Anand Surana's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Micro Labs's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)